Search

Displaying results 7161 - 7170 of 10000 in total
  1. Drug

    Simotaxel

    go.drugbank.com/drugs/DB15384
    Investigational

    Simotaxel is under investigation in clinical trial NCT00088647 (Study Evaluating MST-997 in Advanced Malignant Solid Tumors).

  2. Drug

    Navoximod

    go.drugbank.com/drugs/DB15439
    Investigational

    Navoximod is under investigation in clinical trial NCT02048709 (Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors).

  3. Drug

    Norleucine

    go.drugbank.com/drugs/DB15458
    Investigational

    Norleucine is under investigation in clinical trial NCT00081952 (Amino Acid Therapy for Hot Flashes in Postmenopausal Women).

  4. Drug

    CDC-801

    go.drugbank.com/drugs/DB15640
    Investigational

    CDC-801 is under investigation in clinical trial NCT00006097 (Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia).

  5. Drug

    BFH772

    go.drugbank.com/drugs/DB16035
    Investigational

    BFH772 is under investigation in clinical trial NCT01449591 (Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients).

  6. Drug

    Epigallo Catechin Gallate

    go.drugbank.com/drugs/DB16120
    Investigational

    Epigallo Catechin Gallate is under investigation in clinical trial NCT00799890 (Sunphenon in Progressive Forms of Multiple Sclerosis).

  7. Drug

    Kynurenic Acid

    go.drugbank.com/drugs/DB11937
    Investigational

    Kynurenic Acid is under investigation in clinical trial NCT02340325 (FS2 Safety and Tolerability Study in Healthy Volunteers).

  8. Drug

    Dextromethadone

    go.drugbank.com/drugs/DB15198
    Investigational

    Dextromethadone is under investigation in clinical trial NCT00588640 (Study of D-Methadone in Patients With Chronic Pain).

  9. Drug

    Pimivalimab

    go.drugbank.com/drugs/DB16667
    Investigational

    Pimivalimab is under investigation in clinical trial NCT04549025 (Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After

  10. Drug

    Pixatimod

    go.drugbank.com/drugs/DB19166
    Investigational

    in MSS Metastatic Colorectal Carcinoma (Mcrc)). … Pixatimod is under investigation in clinical trial NCT05061017 (Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide